Trials / Completed
CompletedNCT01476176
A Pharmacokinetic Study of an Experimental Paracetamol Formulation
A Pivotal Pharmacokinetic Study Investigating the Extent of Absorptions of Paracetamol and Caffeine for Two Different Paracetomol Formulations Containing Caffeine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This PK study is designed to show bioequivalence between the study treatments.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Experimental paracetamol | experimental paracetamol with caffeine |
| DRUG | Paracetamol marketed formulation | marketed formulation containing caffeine |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2011-11-22
- Last updated
- 2014-11-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01476176. Inclusion in this directory is not an endorsement.